Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 618442-57-2 | MDL No. : | MFCD28015750 |
Formula : | C30H35B2NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | BMKVLWGCSCKZTD-UHFFFAOYSA-N |
M.W : | 495.23 | Pubchem ID : | 12177223 |
Synonyms : |
|
Num. heavy atoms : | 37 |
Num. arom. heavy atoms : | 19 |
Fraction Csp3 : | 0.4 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 153.73 |
TPSA : | 41.85 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -4.37 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 6.97 |
Log Po/w (WLOGP) : | 5.38 |
Log Po/w (MLOGP) : | 3.43 |
Log Po/w (SILICOS-IT) : | 3.94 |
Consensus Log Po/w : | 3.94 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -7.48 |
Solubility : | 0.0000163 mg/ml ; 0.0000000328 mol/l |
Class : | Poorly soluble |
Log S (Ali) : | -7.66 |
Solubility : | 0.0000108 mg/ml ; 0.0000000217 mol/l |
Class : | Poorly soluble |
Log S (SILICOS-IT) : | -9.68 |
Solubility : | 0.000000105 mg/ml ; 0.0000000002 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 4.06 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45% | With tetrakis(triphenylphosphine) palladium(0); potassium acetate In 1,4-dioxane for 5 h; Reflux | 3,6-dibromo-N-phenylcarbazole (0.075 mol) was dissolved in 300 ml of dioxane,Under the addition of bis (pinacolato) diboron (0.164 mol)Potassium acetate (0.375 mol),Tetrakis (triphenylphosphine) palladium (0.00075 mol)And heated to reflux reaction 5h,The reaction was complete and the reaction was quenched and the reaction was quenched with dichloromethane and water. The organic phase was passed through a silica gel funnel and the organic phase was dried under reduced pressure. The resulting solid was subjected to column chromatography to give compound 203-1 (yield 45percent) |
[ 1246669-45-3 ]
9-Phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole
Similarity: 1.00
[ 1126522-69-7 ]
9-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole
Similarity: 1.00
[ 1035631-57-2 ]
9-Phenyl-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole
Similarity: 1.00
[ 1493715-28-8 ]
9-(Naphthalen-2-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole
Similarity: 1.00
[ 785051-54-9 ]
9-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-9H-carbazole
Similarity: 1.00